Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
Affiliations: Department of Pediatric Cardiology, Onasseio Cardiac Surgery Center, 17674 Athens, Greece, Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece, General Chemical State Laboratory of Greece, 11521 Athens, Greece, Preventive Cardiology and Lipoprotein Apheresis Unit, Metropolitan Hospital, 18547 Piraeus, Greece, Laboratory of Toxicology and Forensic Sciences, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece, YGEIA Diagnostics, Private Practitioner, 20131 Korinthos, Greece, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Department of Internal Medicine, Faculty of Medicine, University Hospital of Ioannina, 45110 Ioannina, Greece
- Published online on: May 13, 2022 https://doi.org/10.3892/etm.2022.11371
- Article Number: 444
Copyright: © Hoursalas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.